Literature DB >> 25966714

Obstetric outcomes of human herpes virus-2 infection among pregnant women in Benin, Nigeria.

E I Kalu, C K Ojide1, A Chuku, I I Chukwuonye, F E Agwu, V U Nwadike, F C Korie, G O C Okafor.   

Abstract

OBJECTIVE: This study investigated the obstetric outcomes of herpes simplex virus (HSV-2) infection among pregnant women.
MATERIALS AND METHODS: In this prospective cohort study, a total of 674 consenting pregnant women attending ante-natal clinic in the University of Benin Teaching Hospital and Central Hospital Benin were recruited between November 2011 and December, 2012. The women were screened for HSV-1, and HSV-2 using glycoprotein-G-based type-specific Enzyme Linked Immunosorbent Assay on archived blood samples; and were followed up to the delivery period and postnatal clinic. The HSV-2-seronegative participants underwent second blood sampling for HSV-2 IgG and IgM assay during the delivery period. The patients were thus categorized into "HSV-2 seropositive", "HSV-2-seronegative," and "incident HSV-2 infection" cohorts. The pregnancy outcomes were assessed by review of hospital records. Data analysis was with SPSS version 16 software.
RESULTS: Of 674 pregnant women surveyed, 312 (46.3%) were HSV-2 seropositive; while 362 (56.7%) were HSV-2 seronegative. Comparing the "HSV-2 seropositive" and "HSV-seronegative" groups, there were no significant differences in occurrence of low birth weight (LBW), prematurity, spontaneous abortions, and stillbirth events (P=0.96; 0.95; 1.0; and 0.77, respectively). Comparing the "incident HSV-2 infection" with the "HSV-2 seronegative" groups, the relative risks of occurrence of LBW deliveries, preterm deliveries, and stillbirths were 12.6, 25.1, and 4.5, respectively.
CONCLUSION: First episode HSV-2 infection among pregnant women in Benin, Nigeria is associated with an increased risk of occurrence of spontaneous abortion, LBW delivery, stillbirths, and preterm delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966714     DOI: 10.4103/1119-3077.154210

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  6 in total

1.  Viral Infection Sensitizes Human Fetal Membranes to Bacterial Lipopolysaccharide by MERTK Inhibition and Inflammasome Activation.

Authors:  Sarah N Cross; Julie A Potter; Paulomi Aldo; Ja Young Kwon; Mary Pitruzzello; Mancy Tong; Seth Guller; Carla V Rothlin; Gil Mor; Vikki M Abrahams
Journal:  J Immunol       Date:  2017-09-15       Impact factor: 5.422

2.  Seroprevalence of herpes simplex virus types 1 and 2 in Nigeria: a systematic review and meta-analyses.

Authors:  Eleazar E Reward; Sophia O Muo; Ibuchukwu N A Orabueze; Anthony C Ike
Journal:  Pathog Glob Health       Date:  2019-10-24       Impact factor: 2.894

3.  Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial.

Authors:  Sarah Nakubulwa; Dan K Kaye; Freddie Bwanga; Nazarius Mbona Tumwesigye; Edith Nakku-Joloba; Florence Mirembe
Journal:  Reprod Health       Date:  2017-03-03       Impact factor: 3.223

4.  Herpes Simplex Virus Type 2 (HSV-2) and Cytomegalovirus (CMV) among Women with Macerated Stillbirth: A Cross-Sectional Hospital-Based Study from Mwanza, Tanzania.

Authors:  Helmut A Nyawale; Elieza Chibwe; Fridolin Mujuni; Lidya Maiga; Albert Silvin; Alda Ester Chongo; Bertrand Msemwa; Vitus Silago; Mtebe Majigo; Doreen Kamori; Stephen E Mshana; Mariam M Mirambo
Journal:  J Pregnancy       Date:  2022-09-08

5.  Herpes simplex virus: global infection prevalence and incidence estimates, 2016.

Authors:  Charlotte James; Manale Harfouche; Nicky J Welton; Katherine Me Turner; Laith J Abu-Raddad; Sami L Gottlieb; Katharine J Looker
Journal:  Bull World Health Organ       Date:  2020-03-25       Impact factor: 9.408

6.  Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model.

Authors:  Allison M Felker; Philip Nguyen; Charu Kaushic
Journal:  Viruses       Date:  2021-09-25       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.